flurbiprofen has been researched along with Genetic Diseases in 1 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiang, L | 1 |
| Guan, Y | 1 |
| Li, X | 1 |
| Liu, L | 1 |
| Mu, Y | 1 |
| Sugano, A | 1 |
| Takaoka, Y | 1 |
| Sakaeda, T | 1 |
| Imbimbo, BP | 1 |
| Yamamura, KI | 1 |
| Jin, S | 1 |
| Li, Z | 1 |
1 trial available for flurbiprofen and Genetic Diseases
| Article | Year |
|---|---|
CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.
Topics: Amyloidosis; Cyclopropanes; Flurbiprofen; Genetic Diseases, Inborn; Humans; Prealbumin; Thyroxine | 2017 |